God, it's brutal out here

No better way to kick off this next chapter than spending my first full day in Boston—after 8 years in California—at the MassBio conference. Grateful for the warm welcome and excited for what’s ahead.

Feels like Christmas morning—can’t wait to read this one!
@charlespiller.bsky.social

Why limit yourself to developing neurodegenerative therapies when you can also create art?

With a cofounder who’s both a scientist and an artist, the possibilities are endless 👨🏻‍🔬👨🏻‍🎨

Excited to share that I'll be attending the Global Healthspan Summit 2025 as Momentum Therapeutics continues advancing our mission to develop novel therapies that protect the nervous system and combat aging.

If you'll be there, let’s connect!

#Hevolution #Healthspan #GHS2025

This is the mantra.

Insitro’s CEO Daphne Koller for Endpoints:

Brain delivery has the potential to transform patient care - and it could become a reality soon. This snapshot of transcytosis strategies (from GS) highlights how neurobiotech is on the verge of revolutionizing treatments for CNS diseases. I only wish Montara had been included in the discussion.

A sincere and shameless plug: This Thanksgiving, I’m especially grateful for my healthy axons.

Photo Credit: Felipe Court, our Chief Scientific Officer.